HSA — authorised 26 November 2018
- Marketing authorisation holder: LOXO ONCOLOGY INC
- Status: likely_approved
🇸🇬 Vitrakvi in Singapore
HSA authorised Vitrakvi on 26 November 2018
Marketing authorisation
Vitrakvi in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Singapore
Frequently asked questions
Is Vitrakvi approved in Singapore?
Yes. HSA authorised it on 26 November 2018.
Who is the marketing authorisation holder for Vitrakvi in Singapore?
LOXO ONCOLOGY INC holds the Singaporean marketing authorisation.